Woodline Partners LP Sells 183,157 Shares of Teleflex Incorporated (NYSE:TFX)

Woodline Partners LP reduced its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 60.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,345 shares of the medical technology company's stock after selling 183,157 shares during the quarter. Woodline Partners LP owned 0.26% of Teleflex worth $21,597,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in TFX. Barclays PLC boosted its stake in shares of Teleflex by 1.6% in the 3rd quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock worth $22,233,000 after buying an additional 1,426 shares during the last quarter. Genesis Private Wealth LLC bought a new stake in Teleflex during the fourth quarter worth $211,000. Janney Montgomery Scott LLC boosted its position in Teleflex by 9.1% in the fourth quarter. Janney Montgomery Scott LLC now owns 16,723 shares of the medical technology company's stock worth $2,976,000 after purchasing an additional 1,391 shares during the last quarter. Avior Wealth Management LLC boosted its position in Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after purchasing an additional 125 shares during the last quarter. Finally, Hengehold Capital Management LLC grew its stake in Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock valued at $229,000 after purchasing an additional 88 shares during the period. 95.62% of the stock is owned by institutional investors.

Teleflex Price Performance

Shares of TFX traded up $0.01 during midday trading on Monday, hitting $120.95. 504,858 shares of the company traded hands, compared to its average volume of 634,984. Teleflex Incorporated has a one year low of $119.08 and a one year high of $249.91. The firm has a market cap of $5.34 billion, a P/E ratio of 24.05, a PEG ratio of 1.73 and a beta of 1.17. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a 50-day moving average of $131.43 and a 200-day moving average of $159.55.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.21 EPS. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.12%. The ex-dividend date is Tuesday, May 20th. Teleflex's dividend payout ratio is currently 42.90%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on TFX. Mizuho set a $155.00 target price on shares of Teleflex in a research report on Wednesday, April 16th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Royal Bank of Canada decreased their target price on Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a research report on Friday, May 2nd. Morgan Stanley dropped their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. Finally, Wall Street Zen downgraded Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.